Yunlong Richard Cao on X: It's critical to test how these RBD hotspots could combine to achieve max immune evasion without losing affinity to ACE2. After careful consideration, besides the emerging K478R/F456L
Yunlong Richard Cao on X: Updates on BA.2.86. 1) BA.2.86's ACE2 binding affinity is very high. 2) BA.2.86 has lower fusogenicity than XBB.1.5. 3) BA.2.86's infectivity in Vero cells is similar to
Yunlong Cao Lab Peking University
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
Yunlong Cao Lab Peking University
A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants
The Potential for SARS-CoV-2 to Evade Both Natural and Vaccine-induced Immunity
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
Viruses, Free Full-Text
The Potential for SARS-CoV-2 to Evade Both Natural and Vaccine-induced Immunity
Biomedicines, Free Full-Text
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants
Yunlong Cao Lab Peking University
Yunlong Richard Cao (@yunlong_cao) / X
IJMS, Free Full-Text